Neuroendocrine tumours trials in Argentina

2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

  Where

  CABA, Ciudad Autónoma de Bs As, Munro, Rosario

  Age

  18 years and over

  People

  390 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT07544654 · EU 2025-523869-22-00
• No phaseTaking people
  Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America

  Where

  Buenos Aires

  Age

  18 years and over

  People

  200 worldwide

  Run by

  Latin American Cooperative Oncology Group

  See details and how to joinNCT07192991